Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Thrombectomy: Features

Interview
Latest Advancements in Coronary Thrombus Removal
04/11/2023
VDM spoke with interventional cardiologist Sanjit Jolly, MD, about the use of thrombectomy devices in PCI, specifically the Indigo® System CAT™ RX (Penumbra) for the removal of emboli and thrombi from the coronary vasculature.
VDM spoke with interventional cardiologist Sanjit Jolly, MD, about the use of thrombectomy devices in PCI, specifically the Indigo® System CAT™ RX (Penumbra) for the removal of emboli and thrombi from the coronary vasculature.
VDM spoke with interventional...
04/11/2023
Vascular Disease Management
Editor's Corner
COVID-19 and Cardiovascular Complications: Still Many Unanswered Questions
03/27/2023
Dr. Walker comments on “Acute Limb Ischemia as a Complication of COVID-19.” He discusses the authors' findings and addresses unanswered questions that remain about COVID-19 and cardiovascular complications.
Dr. Walker comments on “Acute Limb Ischemia as a Complication of COVID-19.” He discusses the authors' findings and addresses unanswered questions that remain about COVID-19 and cardiovascular complications.
Dr. Walker comments on “Acute...
03/27/2023
Vascular Disease Management
Original Research
Acute Limb Ischemia as a Complication of COVID-19
03/16/2023
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
One of the many complications of COVID-19 is blood hypercoagulability, which can result in acute limb ischemia (ALI). This study was conducted to present ALI as a complication of hypercoagulability caused by COVID-19 in a hospital in...
One of the many complications of...
03/16/2023
Vascular Disease Management
Interview
Latest Advancements in Thrombectomy With Lightning Flash
03/09/2023
VDM spoke with vascular surgeon Patrick Muck, MD, about the latest advancements in mechanical thrombectomy and his use of the advanced mechanical thrombectomy system Lightning Flash (Penumbra) for PE.
VDM spoke with vascular surgeon Patrick Muck, MD, about the latest advancements in mechanical thrombectomy and his use of the advanced mechanical thrombectomy system Lightning Flash (Penumbra) for PE.
VDM spoke with vascular surgeon...
03/09/2023
Vascular Disease Management
Editor's Corner
A Creative Application to Leverage Thrombectomy Tools to Achieve Flow Restoration
01/20/2023
Dr. S. Jay Mathews provides a guest editorial to discuss a unique case of ClotTriever (Inari Medical) thrombectomy within a femoralfemoral venous bypass.
Dr. S. Jay Mathews provides a guest editorial to discuss a unique case of ClotTriever (Inari Medical) thrombectomy within a femoralfemoral venous bypass.
Dr. S. Jay Mathews provides a...
01/20/2023
Vascular Disease Management
ISET 2023
Congratulations to the ISET 2023 Poster Winners!
01/19/2023
In a ceremony on Tuesday night, the ISET 2023 Poster Winners were announced.
In a ceremony on Tuesday night, the ISET 2023 Poster Winners were announced.
In a ceremony on Tuesday night,...
01/19/2023
Vascular Disease Management
Case Report
Patency Restored to an Occluded Femoralfemoral Venous Bypass Graft With the ClotTriever Thrombectomy System
01/19/2023
The author describes a previously untested use of the ClotTriever System (Inari Medical) to recanalize a totally occluded, rare femoralfemoral venous graft.
The author describes a previously untested use of the ClotTriever System (Inari Medical) to recanalize a totally occluded, rare femoralfemoral venous graft.
The author describes a...
01/19/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Safety and Performance of Aspiration Thrombectomy for Lower Extremity Acute Limb Ischemia: STRIDE Interim Analysis
01/17/2023
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent meta-analysis, the reported rate of 30-day limb salvage in patients with acute limb ischemia (ALI) after surgical intervention was 83.1%. The purpose of this interim analysis is to report safety and performance data from...
Purpose: In a recent...
01/17/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Improvement in Clinical and Echo Parameters After Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism
01/17/2023
Purpose: To evaluate recovery in patients with acute pulmonary embolism (PE), clinicians rely on clinical parameters and imaging. Right ventricular (RV) size and clot burden are typically evaluated using computed tomography; however,...
Purpose: To evaluate recovery in patients with acute pulmonary embolism (PE), clinicians rely on clinical parameters and imaging. Right ventricular (RV) size and clot burden are typically evaluated using computed tomography; however,...
Purpose: To evaluate recovery in...
01/17/2023
Vascular Disease Management
ISET 2023 ABSTRACT
Computer-Aided Aspiration Thrombectomy for the Treatment of Pulmonary Embolism: Interim Analysis of the STRIKE-PE Study
01/17/2023

I. Weinberg, S. Y. Dohad, W. B. Keeling, J. M. Moriarty, K. M. Sterling

I. Weinberg, S. Y. Dohad, W. B. Keeli...
Purpose: The objective of the STRIKE-PE study is to evaluate real-world long-term functional outcomes, safety, and performance of computer-aided mechanical aspiration thrombectomy with the Indigo Aspiration System (Penumbra) for the treatment...
Purpose: The objective of the STRIKE-PE study is to evaluate real-world long-term functional outcomes, safety, and performance of computer-aided mechanical aspiration thrombectomy with the Indigo Aspiration System (Penumbra) for the treatment...
Purpose: The objective of the...
01/17/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement